El carcinoma prostático hormonorresistente

Silvestris, N; D'Aprile, M; Berardi, T; Di Cosimo, S; Sciacca, V; lorusso, V

El carcinoma prostático hormonorresistente / Hormone-resistant prostate cancer

Silvestris, N; D'Aprile, M; Berardi, T; Di Cosimo, S; Sciacca, V; lorusso, V.

Silvestris, N; s.af
D'Aprile, M; s.af
Berardi, T; s.af
Di Cosimo, S; s.af
Sciacca, V; s.af
lorusso, V; s.af

Oncol. clín ; 9(4): 1127-1135, nov. 2004. tab

Article in Spanish | LILACS | ID: lil-400909

Subject(s)

Humans; Male; Prostatic Neoplasms; Antineoplastic Agents, Hormonal; Antineoplastic Agents/therapeutic use; Calcitriol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diphosphonates; Drug Resistance, Neoplasm; Estramustine; Granulocyte-Macrophage Colony-Stimulating Factor; Metalloproteins/antagonists & inhibitors; Mitoxantrone; Paclitaxel; Prostatic Neoplasms; Radiopharmaceuticals; Suramin; Survival Rate; Thalidomide; Treatment Outcome; Vinblastine; Vinca Alkaloids

Search on Google

XML

Index: LILACS (Americas) Main subject: Prostatic Neoplasms Limits: Humans / Male Language: Spanish Journal: Oncol. clín Journal subject: Neoplasms Year: 2004 Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML